Notice - Prescription Drug List (PDL): Mometasone furoate
Description
The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing for Adrenocortical hormones on the Prescription Drug List (PDL) to allow the nonprescription use of Mometasone furoate for the conditions listed below. Only the Human part of the PDL was revised.
Resources
| Name |
Format |
Description |
Link |
| Notice - Prescription Drug List (PDL): Mometasone furoate |
HTML |
|
https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-mometasone-furoate.html |
| Notice - Prescription Drug List (PDL): Mometasone furoate |
HTML |
|
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/liste-drogues-ordonnance/avis-furoate-mometasone.html |